What is the duration of action of levofloxacin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Duration of Action of Levofloxacin

Levofloxacin has a plasma elimination half-life of 6-8 hours in patients with normal renal function, allowing for once-daily dosing with therapeutic drug levels maintained for 24 hours. 1

Pharmacokinetic Profile

The duration of action is determined by levofloxacin's pharmacokinetic characteristics:

  • Elimination half-life: 6-8 hours in normal renal function 1
  • Peak concentration (Cmax): Achieved 1-2 hours after oral administration 1
  • Steady-state trough levels: Detectable at 24 hours post-dose (ranging from 0.107 to 0.164 mcg/mL in animal studies) 2
  • Total plasma exposure (AUC0-24): 47.5 ± 6.7 mcg•h/mL for 500 mg oral dosing 2

Clinical Dosing Implications

The pharmacokinetic profile supports once-daily dosing for most indications 1, 3. The FDA-approved regimens demonstrate this:

  • Standard infections: 250-500 mg once daily
  • Community-acquired pneumonia (high-dose): 750 mg once daily for 5 days 4
  • Complicated UTI/pyelonephritis: 250 mg once daily for 10 days 2

Pharmacodynamic Considerations

The duration of antimicrobial effect extends beyond the plasma half-life due to concentration-dependent killing and post-antibiotic effect. The key pharmacodynamic parameters are 3:

  • AUC0-24/MIC ratio: The critical determinant of efficacy
  • For gram-negative infections: AUC/MIC ≥125 required
  • For S. pneumoniae: AUC/MIC ≥30 for favorable outcomes

This means therapeutic activity persists even as plasma levels decline, supporting the 24-hour dosing interval.

Important Clinical Caveats

Renal impairment significantly prolongs the half-life since approximately 80% of levofloxacin is eliminated unchanged in urine 1. Dosage adjustments are mandatory when creatinine clearance is reduced, as renal clearance and total body clearance are highly correlated with CLCR 1.

In special populations, the half-life may be altered:

  • Obese patients may have shorter half-lives (5.18-6.4 hours documented in one case) 5
  • Elderly patients require consideration of age-related renal function decline

The practical duration of action for once-daily dosing is 24 hours, but this assumes normal renal function and appropriate dosing for the target pathogen's MIC.

References

Research

The clinical pharmacokinetics of levofloxacin.

Clinical pharmacokinetics, 1997

Research

Therapeutic Drug Monitoring of Levoffoxacin in an Obese Adolescent: A Case Report.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.